Medicus Pharma Ltd. MDCX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 22.69M | 20.69M | 17.92M | 14.94M | 11.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.58M | 29.11M | 25.64M | 21.44M | 17.06M |
| Operating Income | -34.58M | -29.11M | -25.64M | -21.44M | -17.06M |
| Income Before Tax | -56.73M | -51.22M | -47.28M | -35.75M | -17.09M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -56.73 | -51.22 | -47.28 | -35.75 | -17.09 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 67.10K | 400.00 | 200.00 | 100.00 | -- |
| Net Income | -56.66M | -51.22M | -47.28M | -35.75M | -17.09M |
| EBIT | -34.58M | -29.11M | -25.64M | -21.44M | -17.06M |
| EBITDA | -- | -- | -- | -3.56M | -5.87M |
| EPS Basic | -122.54 | -133.61 | -139.14 | -114.20 | -69.99 |
| Normalized Basic EPS | -60.65 | -67.16 | -70.75 | -55.37 | -43.31 |
| EPS Diluted | -122.54 | -133.61 | -139.14 | -114.20 | -69.99 |
| Normalized Diluted EPS | -60.65 | -67.16 | -70.75 | -55.37 | -43.31 |
| Average Basic Shares Outstanding | 2.44M | 1.62M | 1.28M | 1.13M | 948.10K |
| Average Diluted Shares Outstanding | 2.44M | 1.62M | 1.28M | 1.13M | 948.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |